Quantcast

Latest Vagus nerve Stories

2014-05-28 08:32:49

HOUSTON, May 28, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the William Blair 34th Annual Growth Stock Conference on Wednesday, June 11, 2014, in Chicago. Greg Browne, Cyberonics' Senior Vice President and Chief Financial Officer, will speak at 12:40 PM Central Time. A live audio webcast of the presentation can be accessed by clicking on the Investor...

2014-05-21 08:29:56

HOUSTON, May 21, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that the company will report financial results for the fourth quarter and fiscal year ended April 25, 2014, on Wednesday, June 4, 2014, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time). Fourth Quarter and Fiscal Year 2014 Results Webcast and Conference Call Instructions The...

2014-05-09 13:42:49

Institute of Physics An implantable device that reduces blood pressure by sending electrical signals to the brain has been created by a group of researchers in Germany. The device has successfully reduced the blood pressure in rats by 40 per cent without any major side effects, and could offer hope for a significant proportion of patients worldwide who do not respond to existing medical treatment for the condition. The first results have been published today, 9 May, in IOP...

2014-05-06 08:36:01

Significant Improvements Observed in Quality-of-Life Measurements and Reduced Seizure Frequency Support VNS Therapy as Foundational Treatment for Refractory Epilepsy HOUSTON, May 6, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced positive results from the PuLsE (Open Prospective Randomized Long-term Effectiveness) study conducted at 28 sites in Europe and Canada and published in the peer-reviewed journal Epilepsia. The goal of this comparative effectiveness...

2014-04-28 08:32:57

HOUSTON, April 28, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced the promotion of Rohan Hoare, Ph.D., to the newly created role of Chief Operating Officer. As COO, Rohan will be responsible for the development, manufacturing, quality and commercial activities for the Epilepsy franchise. The company also announced that O'Neill F. D'Cruz, M.D. recently joined the company as Chief Medical Officer. "We have made significant, multi-year investments in our sales...

2014-02-20 08:29:34

Proprietary Technology Provides Automatic Stimulation upon Seizure Detection HOUSTON, Feb. 20, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) announced today the CE Mark (Conformité Européenne) approval in Europe for the AspireSR generator, the novel sixth-generation VNS Therapy generator. The AspireSR generator provides the well-established benefits of VNS Therapy, coupled with a new feature - Automatic Stimulation in response to detection of a seizure. Proprietary...

2014-02-19 16:24:40

HOUSTON, Feb. 19, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences. Greg Browne, Cyberonics' Chief Financial Officer, will participate in one-on-one meetings with investors during the RBC Capital Markets Global Healthcare Conference in New York on Tuesday, February 25, 2014. No formal presentation is scheduled, and the one-on-one...

2014-02-04 08:36:10

HOUSTON, Feb. 4, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that the company will report financial results for the third quarter ended January 24, 2014, of its fiscal year ending April 25, 2014, on Thursday, February 20, 2014, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time). Fiscal Year 2014 Third Quarter Results Webcast and Conference Call...

2014-01-23 23:24:30

According to Ron Minson, MD, Clinical Director at Integrated Listening Systems (iLs), the manufacturer of the Dreampad, a pilot study measuring the ability of a new product, a pillow which delivers music through vibration, indicates it may help those challenged by stress-related symptoms. Over 80% of those in the study showed a significant relaxation response within 15 minutes of using the pillow. Denver, CO (PRWEB) January 23, 2014 Preliminary research measuring the effect of new...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related